Navigation Links
Cadence Pharmaceuticals Recognized As A Top Workplace In San Diego Based On Employee Feedback
Date:11/8/2013

SAN DIEGO, Nov. 8, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today it has been recognized as one of U-T San Diego's Top Workplaces. The Top Workplaces are determined exclusively based on employee feedback provided through an anonymous survey.

"We are extremely honored that our employees' feedback has resulted in this recognition," said Ted Schroeder, President, CEO, and co-founder of Cadence Pharmaceuticals. "Building and sustaining a great working environment and a strong culture has been a top priority since we founded the company in 2004. The leadership team is focused on driving competitive advantage by consistently fostering a strong set of core values and maintaining our dynamic company culture."

The survey, which was conducted by leading research firm on organizational health and employee engagement, WorkplaceDynamics, LLP, included questions around company direction, execution, connection to the company, management, pay and benefits, and employee engagement. Cadence Pharmaceuticals had an exceptional 92 percent employee response rate on the survey.

"The key to Cadence Pharmaceuticals' employee satisfaction is a culture that encourages employee feedback," said Diane Sheehan, Vice President of Human Resources at Cadence Pharmaceuticals. "Each employee is important to our success, so it is imperative that we gather, consider and take action on their input. We believe that this approach will help as we strive to achieve our corporate objectives and provide value to the hospital community and our business partners."

The following anonymous testimonials were excerpted from the survey:

  • "I truly believe in the product I promote and believe I work with the best people in the industry. Management is transparent and supportive all the way up the chain of command. I have never been more satisfied with work."
  • "I am empowered to make decisions and contribute. Our CEO is accessible and easy to approach. [Cadence Pharmaceuticals has a] strong unique culture in which we can all contribute and be a part of the company's success."

In addition, Cadence Pharmaceuticals was recognized as a recipient of a 2013 Workplace Excellence Award presented by the San Diego Society for Human Resource Management's (SD SHRM). This award, which is based on the assessment of an expert judging panel assembled by SD SHRM, recognizes Cadence Pharmaceuticals' proactive efforts to involve its employees in the ongoing strengthening of the company and its culture. This is the second time Cadence Pharmaceuticals has won a SD SHRM Workplace Excellence Award, with the first award in 2010.

Both awards were presented at a ceremony sponsored by U-T San Diego, held at the Hilton La Jolla Torrey Pines on November 7, 2013.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. The current version of Cadence Pharmaceuticals' corporate overview may be viewed on the Investors page of www.cadencepharm.com under "Events & Presentations" by selecting "Corporate Overview."

Cadence® is a trademark of Cadence Pharmaceuticals, Inc.

Investor Contact:
William R. LaRue   
SVP & Chief Financial Officer    
Cadence Pharmaceuticals, Inc.       
Phone: 858-436-1400                                                                                     

Media Contact:
Cuyler Mayer     
Edelman
Phone: 323-202-1073


'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cadence Pharmaceuticals Reports Third Quarter 2013 Financial Results
2. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2013 Financial Results On November 5, 2013
3. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2013 On September 11, 2013
4. Cadence Pharmaceuticals Comments on USPTOs Non-Final, Initial Office Action on Reexamination of Patent
5. Cadence Pharmaceuticals Appoints Laureen DeBuono to its Board of Directors
6. Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013
7. Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
8. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013
9. Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013
10. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013
11. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 19, 2017 Report Details What ... areas are going to grow at the fastest rates? ... assessing data, trends, opportunities and prospects. Our 190-page ... most lucrative areas in the industry and the future ... sales across the all the major categories of the ...
(Date:1/19/2017)... , Jan. 19, 2017 Report Details ... ... for Leading Companies – our new study reveals trends, ... issues and events affecting the Alzheimer,s disease therapeutics and ... answer these key questions: - How is the Alzheimer,s ...
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, ... anti-obesity drugs market is expected to grow at a CAGR ... CAGR of 38.7% in the second half of the forecast period. ... from 2016 to 2027. The market is estimated at $1,058 million ... ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... Wells Pharmacy Network ... of their 503A compounding pharmacy located in Ocala, Florida. , Meeting the ... patients throughout the United States for high-quality human anti-aging and wellness compounded ...
(Date:1/19/2017)... ... January 19, 2017 , ... LabRoots ... scientists from around the world, announces the launch of its newly redesigned website. ... portal to research breakthroughs and trending news, vital information on upcoming virtual events ...
(Date:1/19/2017)... ... January 19, 2017 , ... Cosmetic Town, an online plastic ... in order to make it easier for their readers to get the information they ... impact as well as the techniques used on those particular areas. , “We are ...
(Date:1/19/2017)... ... January 19, 2017 , ... Dr. ... of Dermatology and fellowship trained Mohs and cosmetic surgeon. After extensive dermatology research ... Li completed his internship in internal medicine at the Emory University and dermatology ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... who administered fillers that resulted in severe facial disfiguration. After four frightening years ... by doctors at UCLA Medical Center, who removed the substances in a partial ...
Breaking Medicine News(10 mins):